|
|
||||||||
B in bronchial biopsies from smokers and patients with COPD
1 Salvatore Maugeri Foundation, IRCCS, Medical Centre of Rehabilitation, Division of Pulmonary Disease, Veruno, Italy. 2 Dept of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, UK
CORRESPONDENCE: I.M. Adcock, Dept of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, London, SW3 6LY, UK. Fax: 44 2073518126. E-mail: ian.adcock@ic.ac.uk
Keywords: airflow limitation, airway inflammation, nuclear factor-
B, T-lymphocytes
Received: August 13, 2001
Accepted March 28, 2002
This study was supported by the Associazione per la Ricerca e la Cura dell'Asma (ARCA, Padua, Italy), Salvatore Maugeri Foundation, IRCCS, "Ricerca Corrente" and Glaxo-Wellcome (UK).
The expression of nuclear factor (NF)-
Bronchial biopsies were obtained from 14 smokers with COPD, 17 smokers with normal lung function and 12 nonsmokers with normal lung function. The number of p65 positive (+) cells was quantified by immunohistochemistry and the expression of p65 in bronchial biopsies from the three groups was examined by Western blotting (WB).
Smokers with normal lung function and patients with COPD had increased numbers of p65+ cells in the epithelium and increased p65 nuclear expression. In COPD patients the number of epithelial p65+ cells correlated with the degree of airflow limitation. WB analysis showed an increase in p65 in smokers with normal lung function and COPD patients (p<0.05).
Bronchial biopsies in smokers with normal lung function and chronic obstructive pulmonary disease patients show increased expression of p65 protein, predominantly in the bronchial epithelium. Disease severity is associated with an increased epithelial expression of nuclear factor-
B is an indicator of cellular activation and of inflammatory mediator production. The aim of the present study was to characterise the expression and localisation of p65, the major subunit of NF-
B, in the bronchial mucosa of patients with chronic obstructive pulmonary disease (COPD), and to examine the relationship between p65 expression and disease status.
B.
This article has been cited by other articles:
![]() |
S. Ying, B. O'Connor, J. Ratoff, Q. Meng, C. Fang, D. Cousins, G. Zhang, S. Gu, Z. Gao, B. Shamji, et al. Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease J. Immunol., August 15, 2008; 181(4): 2790 - 2798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Chung and I. M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-R. Yang, S. Valvo, H. Yao, A. Kode, S. Rajendrasozhan, I. Edirisinghe, S. Caito, D. Adenuga, R. Henry, G. Fromm, et al. IKK{alpha} Causes Chromatin Modification on Pro-Inflammatory Genes by Cigarette Smoke in Mouse Lung Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Stathopoulos, T. P. Sherrill, D.-S. Cheng, R. M. Scoggins, W. Han, V. V. Polosukhin, L. Connelly, F. E. Yull, B. Fingleton, and T. S. Blackwell Epithelial NF-{kappa}B activation promotes urethane-induced lung carcinogenesis PNAS, November 20, 2007; 104(47): 18514 - 18519. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshida and R. M. Tuder Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Physiol Rev, July 1, 2007; 87(3): 1047 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Thatcher, S. B. Maggirwar, C. J. Baglole, H. F. Lakatos, T. A. Gasiewicz, R. P. Phipps, and P. J. Sime Aryl Hydrocarbon Receptor-Deficient Mice Develop Heightened Inflammatory Responses to Cigarette Smoke and Endotoxin Associated with Rapid Loss of the Nuclear Factor-{kappa}B Component RelB Am. J. Pathol., March 1, 2007; 170(3): 855 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rahman and I. M. Adcock Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J., July 1, 2006; 28(1): 219 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Szulakowski, A. J. L. Crowther, L. A. Jimenez, K. Donaldson, R. Mayer, T. B. Leonard, W. MacNee, and E. M. Drost The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marian, S. Baraldo, A. Visentin, A. Papi, M. Saetta, L. M. Fabbri, and P. Maestrelli Up-Regulated Membrane and Nuclear Leukotriene B4 Receptors in COPD Chest, June 1, 2006; 129(6): 1523 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vlahos, S. Bozinovski, J. E. Jones, J. Powell, J. Gras, A. Lilja, M. J. Hansen, R. C. Gualano, L. Irving, and G. P. Anderson Differential protease, innate immunity, and NF-{kappa}B induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L931 - L945. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Corticosteroid effects on cell signalling Eur. Respir. J., February 1, 2006; 27(2): 413 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Reduced Histone Deacetylase in COPD: Clinical Implications Chest, January 1, 2006; 129(1): 151 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Bourbia, M A Cruz, and H J Rozycki NF-{kappa}B in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2006; 91(1): F36 - F39. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. MacNee Pathogenesis of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 258 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Theophylline in Chronic Obstructive Pulmonary Disease: New Horizons Proceedings of the ATS, November 1, 2005; 2(4): 334 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lora, D. M. Zhang, S. M. Liao, T. Burwell, A. M. King, P. A. Barker, L. Singh, M. Keaveney, J. Morgenstern, J. C. Gutierrez-Ramos, et al. Tumor Necrosis Factor-{alpha} Triggers Mucus Production in Airway Epithelium through an I{kappa}B Kinase {beta}-dependent Mechanism J. Biol. Chem., October 28, 2005; 280(43): 36510 - 36517. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes New approaches to COPD Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. MacNee Treatment of stable COPD: antioxidants Eur. Respir. Rev., September 1, 2005; 14(94): 12 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Johnston Overview of Virus-induced Airway Disease Proceedings of the ATS, August 1, 2005; 2(2): 150 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Birrell, S. Wong, D. J. Hele, K. McCluskie, E. Hardaker, and M. G. Belvisi Steroid-resistant Inflammation in a Rat Model of Chronic Obstructive Pulmonary Disease Is Associated with a Lack of Nuclear Factor-{kappa}B Pathway Activation Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 74 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. MacNee Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 50 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Marwick, P. A. Kirkham, C. S. Stevenson, H. Danahay, J. Giddings, K. Butler, K. Donaldson, W. MacNee, and I. Rahman Cigarette Smoke Alters Chromatin Remodeling and Induces Proinflammatory Genes in Rat Lungs Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 633 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Harju, R. Kaarteenaho-Wiik, R. Sirvio, P. Paakko, J.D. Crapo, T.D. Oury, Y. Soini, and V.L. Kinnula Manganese superoxide dismutase is increased in the airways of smokers' lungs Eur. Respir. J., November 1, 2004; 24(5): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.C. Thomson, R. Chaudhuri, and E. Livingston Asthma and cigarette smoking Eur. Respir. J., November 1, 2004; 24(5): 822 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 184 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Schleimer Glucocorticoids Suppress Inflammation but Spare Innate Immune Responses in Airway Epithelium Proceedings of the ATS, November 1, 2004; 1(3): 222 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Cosio, L. Tsaprouni, K. Ito, E. Jazrawi, I. M. Adcock, and P. J. Barnes Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages J. Exp. Med., September 7, 2004; 200(5): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Di Stefano, A. Capelli, and C. F. Donner Role of Interleukin-8 in the Pathogenesis and Treatment of COPD Chest, September 1, 2004; 126(3): 676 - 678. [Full Text] [PDF] |
||||
![]() |
A. Di Stefano, G. Caramori, A. Capelli, I. Gnemmi, F.L. Ricciardolo, T. Oates, C.F. Donner, K.F. Chung, P.J. Barnes, and I.M. Adcock STAT4 activation in smokers and patients with chronic obstructive pulmonary disease Eur. Respir. J., July 1, 2004; 24(1): 78 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellularmechanisms Eur. Respir. J., October 1, 2003; 22(4): 672 - 688. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |